$2.02
+1.0%Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Chief Commercialization Officer
Compensation
$423,492
Chief Executive Officer of Health Care & Director
Compensation
$45,000
Chief Financial Officer, General Counsel & Corporate Secretary
Compensation
$703,971
Chief Operating Officer
Compensation
$372,330
Co-Founder, Chief Innovation Strategist & Senior Advisor to the Chief Executive Officer
Compensation
$1,248,183
Executive Vice President of UK & EMEA
Founder & Chairman
Compensation
$67,500
General Manager
Compensation
$422,730
Vice President of Marketing & Commercialization
Compensation
$349,318
During the last 12 months, insiders have purchased $33K worth of MDAI shares, with no selling activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
16.7K
33.32K
0
0.00
+33K
+$33K
Dimaio John Michael
Director
$25K
Mellish Martin C.B.
Director
$9K
No selling activity
Strong bullish signal with $33K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
2 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
MDAI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 16, 2026 | May 29, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 17, 2025 | May 28, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 04, 2024 | May 14, 2024 | 2024 | |
DEF 14A DEF 14A 2022 N/A | November 28, 2022 | December 21, 2022 | 2022 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.